Edesa Biotech Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year	2023	2022	2021	2020	2018	2017	2016	2015	2014	2013	2012 - 2011
Cash & Equivalents	5.36	7.09	7.84	7.21	3.37	4.57	7.42	3.96	-	7.86	Upgrade
Short-Term Investments	0	0	0	0	0	1.99	3.99	5.02	-	0	Upgrade
Cash & Cash Equivalents	5.36	7.09	7.84	7.21	3.37	6.57	11.41	8.97	0	7.86	Upgrade
Cash Growth	-24.39%	-9.55%	8.67%	114.24%	-48.71%	-42.44%	27.14%	-	-	686.78%	Upgrade
Receivables	0.63	1.26	3.3	0.09	0.01	0	0.09	0.16	-	0.18	Upgrade
Inventory	0	0	0	0	0	0.07	0.25	0.56	-	0	Upgrade
Other Current Assets	0.45	0.75	0.95	0.8	0.02	0.12	0.36	0.18	-	0.1	Upgrade
Total Current Assets	6.44	9.09	12.09	8.1	3.39	6.76	12.1	9.87	-	8.13	Upgrade
Property, Plant & Equipment	0.1	0.03	0.11	0.17	0.01	0.88	0.76	0.5	-	0.25	Upgrade
Long-Term Investments	0.17	0.17	0	0	0	0.08	0.08	0.02	-	0.02	Upgrade
Goodwill and Intangibles	2.18	2.28	2.38	2.48	0	0	0	0	-	0.12	Upgrade
Total Long-Term Assets	2.45	2.48	2.49	2.66	0.01	0.96	0.84	0.52	-	0.38	Upgrade
Total Assets	8.89	11.58	14.58	10.76	3.4	7.72	12.94	10.39	-	8.51	Upgrade
Accounts Payable	1.75	2.17	1.43	1.49	0.18	0.32	0.62	0.66	-	0.42	Upgrade
Deferred Revenue	0	0	0	0	0	0	0	0.17	-	0	Upgrade
Current Debt	0.07	0.02	0.08	0.07	0	0	0	0	-	0	Upgrade
Other Current Liabilities	0	-0.04	-0.05	-0.03	0	0	0	1.55	-	3.45	Upgrade
Total Current Liabilities	1.82	2.14	1.46	1.53	0.18	0.32	0.62	2.38	-	3.87	Upgrade
Long-Term Debt	0.02	0	0.02	0.09	0	0	0	0	-	0	Upgrade
Other Long-Term Liabilities	0	0.04	0.05	0.03	0	0	0	0	-	6.84	Upgrade
Total Long-Term Liabilities	0.02	0.04	0.07	0.12	0	0	0	0	-	6.84	Upgrade
Total Liabilities	1.84	2.18	1.53	1.65	0.18	0.32	0.62	2.38	-	10.71	Upgrade
Total Debt	0.09	0.02	0.1	0.16	0	0	0	0	-	0	Upgrade
Debt Growth	397.96%	-80.90%	-39.51%	-	-	-	-	-	-	-	Upgrade
Retained Earnings	-52.42	-44.04	-26.5	-13.13	-3.76	-45.39	-40.36	-35.34	-	-25.18	Upgrade
Comprehensive Income	-0.21	-0.21	-0.21	-0.29	-0.43	0	0	0	-	0	Upgrade
Shareholders' Equity	7.05	9.39	13.06	6.63	3.21	7.4	12.31	8.01	-	-2.2	Upgrade
Net Cash / Debt	5.27	7.07	7.74	7.05	3.37	6.57	11.41	8.97	0	7.86	Upgrade
Net Cash / Debt Growth	-25.52%	-8.63%	9.79%	109.36%	-48.71%	-42.44%	27.14%	-	-	686.78%	Upgrade
Net Cash Per Share	1.84	3.37	4.49	5.73	7.27	188.55	379.92	331.46	-	447.73	Upgrade
Working Capital	4.61	6.95	10.63	6.57	3.21	6.44	11.48	7.49	-	4.26	Upgrade
Book Value Per Share	2.47	4.48	7.57	5.39	6.95	212.49	410.18	295.79	-	-125.09	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).